# TELA Bio, Inc.

- Location (FDA's records): Malvern, PA
- FDA decisions: 5 (2014–2026): 5 510(k) clearances
- Names in FDA's records: TELA Bio, Inc. (4); Tela Bio (1)
- Product codes: FTM (4), FTL (1)
- Predicates its devices cite: 5 (1 its own); citations of its devices by later devices: 2 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Aroa Biosurgery, Ltd.: 2 (https://510kreport.com/company/aroa-biosurgery)
- Mesynthe, Ltd.: 1 (https://510kreport.com/company/mesynthe)
- Lntegra Lifesciences: 1 (https://510kreport.com/company/lntegra-lifesciences)

## Firms that cite its devices most
- Aroa Biosurgery Limited (Formerly Mesynthes Limited): 1 (https://510kreport.com/company/aroa-biosurgery-formerly-mesynthes)

## Its most-cited devices
- K214070: OviTex PRS (Long Term Resorbable) (2023), cited by 1
- K141053: Ovine Tissue Matrix (Otm) (2014), cited by 1

## Recent decisions
- K260474: Liora Monofilament Scaffold (Sep 28, 2026)
- K243595: OviTex PRS (Long-Term Resorbable) (Dec 19, 2024)
- K241126: OviTex PRS (May 22, 2024)
- K214070: OviTex PRS (Long Term Resorbable) (Mar 21, 2023)
- K141053: Ovine Tissue Matrix (Otm) (Dec 11, 2014)

Source page: https://510kreport.com/company/tela-bio